Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients
✍ Scribed by I.M Dijkema; H Struikmans; H.F.J Dullens; H.B Kal; I van der Tweel; J.J Battermann
- Book ID
- 114394389
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 131 KB
- Volume
- 36
- Category
- Article
- ISSN
- 1368-8375
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Reports that have both evaluated the site-specific epstein-barr virus (ebv) infection and compared it with the expression of the ebv-related proto-oncogenes and tumor suppressor genes in the various cancers of head and neck are scarce. ## Methods: Thirty-eight nasopharyngeal carcin
We investigated the prognostic significance of p53-gene mutation (exon 5-9) and bcl-2-protein expression in primary squamous-cell carcinoma of the head and neck (HNSCC) treated by curative radiotherapy (RT). Primary squamouscell carcinomas for analysis were obtained from 85 consecutive head-and-neck